Case Study: Valeant Pharmaceuticals achieves streamlined IIS and CME grant review with Benevity

Valeant Pharmaceuticals - Customer Case Study

Valeant Pharmaceuticals, a multinational specialty pharmaceutical and medical device company, needed a better way to manage Investigator Initiated Studies (IIS) and Continuing Medical Education (CME) grant requests after its prior system was slow, error‑prone and required extensive manual work. To address gaps like handling concept vs. full applications, separate therapeutic reviewers, and timely processing, Valeant turned to Benevity’s online request‑management portal to streamline engagement with researchers and healthcare professionals.

Benevity configured a flexible platform to Valeant’s processes—providing Quick View access, email templates, automated reconciliation, and routing/reporting tools—so submissions are tracked, reviewed and reported reliably while maintaining compliance. The Benevity solution reduced manual effort, sped processing and improved committee review workflows, enabling Valeant to better identify and fund high‑impact research and continuing education programs.

Valeant Pharmaceuticals

Teneisha Boisseau

Medical Affairs